1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow David Piccioni, M.D., Ph.D: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of Dacomitinib in Progressive Brain Metastases Dacomitinib - Brain Cancer | Phase 2 | Terminated | David Piccioni, M.D., Ph.D | 4 | 2014-02-01 | 2016-09-22 |
| Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas nilotinib - Glioma | Phase 2 | Completed | David Piccioni, M.D., Ph.D | 38 | 2010-04-21 | 2020-05-05 |
Brain Neoplasms (1) · Glioma (1) · Neoplasm Metastasis (1)
dacomitinib (1) · nilotinib (1)
United States (2)
David Piccioni, M.D., Ph.D. (1) · David Piccioni, MD, PhD (1)